By Counterforce Health Team in Takhzyro (lanadelumab-flyo) —

Get Takhzyro (lanadelumab-flyo) Covered by Humana in New Jersey: PA Forms, Appeals & IHCAP Guide

Answer Box: Getting Takhzyro (lanadelumab-flyo) Covered by Humana in New Jersey

Takhzyro requires prior authorization from Humana and is typically covered as a Tier 4 specialty drug through CenterWell Specialty Pharmacy. Your fastest path: 1) Have your HAE specialist submit a PA request via Humana's provider portal with confirmed HAE Type I/II diagnosis (C4 <14 mg/dL, C1-INH functional activity <50%) and attack documentation. 2) If denied, file an internal appeal within 65 days. 3) Use New Jersey's IHCAP external review within 4 months of final denial. Start with Humana's PA form here.

Table of Contents

Plan Types & Coverage Implications

Humana operates several plan types in New Jersey, each with different coverage rules for Takhzyro (lanadelumab-flyo):

Medicare Advantage Plans: Humana's largest New Jersey presence, covering Takhzyro under Part D (pharmacy benefit) with prior authorization required. These plans must follow federal Medicare guidelines while maintaining their own formulary restrictions.

Commercial Plans: Less common in New Jersey's market dominated by Horizon Blue Cross Blue Shield (~39% market share), but available through some employers. Coverage varies by specific plan design.

Medicaid Plans: Humana Healthy Horizons operates in select New Jersey counties, with Takhzyro requiring PA and medical necessity documentation.

Note: Your appeal rights differ by plan type. Medicare Advantage follows federal timelines, while commercial plans use New Jersey's IHCAP external review process.

Formulary Status & Tier Placement

Tier 4 Specialty Classification: Takhzyro appears on Humana's 2025 Medicare formularies as a Tier 4 specialty drug, meaning higher cost-sharing but guaranteed coverage once PA criteria are met.

Alternative Agents: Humana typically prefers these HAE prophylaxis options:

  • Haegarda (C1-INH subcutaneous) - often Tier 3
  • Orladeyo (berotralstat oral) - may have preferred status
  • Cinryze (C1-INH IV) - hospital/clinic administration

Non-Formulary Scenarios: If Takhzyro isn't on your specific plan's formulary, you can request a formulary exception with clinical justification showing preferred alternatives are ineffective or contraindicated.

Prior Authorization Requirements

Coverage at a Glance

Requirement What It Means Where to Find It Source
PA Required Yes, for all Humana plans Humana PA Lists Verified 2024-2025
Age Limit ≥2 years old FDA labeling Takhzyro Prescribing Info
Diagnosis HAE Type I or II confirmed Lab values required C4 <14 mg/dL, C1-INH <50%
Attack History Documented frequency/severity Medical records Provider documentation
Specialty Pharmacy CenterWell required Network restriction CenterWell Info

Medical Necessity Criteria

Your HAE specialist must document:

  1. Confirmed HAE Type I or II diagnosis with lab evidence:
    • C4 level <14 mg/dL
    • C1-INH functional activity <50%
    • Normal C1q (to rule out acquired angioedema)
  2. Attack burden documentation:
    • Frequency (typically ≥1 moderate-severe attack per month)
    • Severity (ED visits, hospitalizations, missed work/school)
    • Impact on quality of life
  3. Prior therapy failures or contraindications:
    • Inadequate response to on-demand treatments
    • Contraindications to androgens or other prophylaxis
    • Specific reasons other HAE prophylaxis agents aren't suitable

Specialty Pharmacy Network

CenterWell Specialty Pharmacy Requirement: Humana mandates Takhzyro dispensing through their owned specialty pharmacy network. Out-of-network fills typically aren't covered.

CenterWell Services:

  • Prior authorization coordination
  • Cold-chain shipping and handling
  • Injection training and support
  • Adherence monitoring
  • Benefits verification

Contact Information: 1-800-486-2668 (TTY: 711) for enrollment and coordination.

Tip: CenterWell will handle most PA submission details once your prescriber sends the initial prescription and clinical documentation.

Cost-Share Dynamics

Tier 4 Specialty Costs: Expect 25-33% coinsurance for most Medicare Advantage plans, with potential monthly maximums. Commercial plans vary widely.

Deductible Application: Specialty tiers often apply after medical/pharmacy deductible is met. Check your Evidence of Coverage for specific details.

Cost Protection: Medicare's catastrophic coverage and out-of-pocket maximums provide some protection, but initial costs can be substantial.

Note: This is educational information only. Contact Humana member services for your specific cost-sharing details.

Step-by-Step: Fastest Path to Approval

1. Verify Coverage and PA Requirements

Who: Patient or clinic staff
Action: Call Humana member services (number on insurance card) or check online portal
Timeline: Same day
Source: MyHumana Portal

2. Gather Required Documentation

Who: HAE specialist and clinic
Documents Needed:

  • Confirmed HAE diagnosis with lab values
  • Attack frequency and severity logs
  • Prior therapy documentation
  • Medical necessity letter addressing Humana's criteria Timeline: 1-2 weeks to compile

3. Submit PA Request

Who: Prescriber's office
Method: Humana provider portal or fax using Humana's Takhzyro PA form
Timeline: Humana decision within 72 hours (standard) or 24 hours (expedited)

4. CenterWell Enrollment

Who: Patient with CenterWell support
Action: Complete specialty pharmacy enrollment, insurance verification, and delivery setup
Timeline: 3-5 business days after PA approval

5. Monitor and Prepare for Reauthorization

Who: Patient and clinic
Action: Track attack frequency reduction, prepare annual reauth 90 days before expiration
Timeline: Ongoing, with annual renewal

Appeals Playbook for New Jersey

Internal Appeals (Humana)

Level 1 - Plan Reconsideration

  • Deadline: 65 days from denial notice date
  • Method: Call number on denial notice or submit written appeal
  • Timeline: 30 days (Part C medical), 7 days (Part D pharmacy), 72 hours (expedited)
  • Required: Copy of denial, clinical support letter, medical records

Level 2 - Independent Review Entity (IRE)

  • Automatic: For most Medicare Advantage denials
  • Timeline: Similar to Level 1
  • Focus: Independent medical review of Humana's decision

New Jersey IHCAP External Review

Eligibility: After completing Humana's internal appeals for medical necessity denials

Timeline:

  • Filing deadline: 4 months (180 days) after final internal denial
  • Standard review: 45 days for decision
  • Expedited review: 72 hours if delay could seriously harm health

How to File:

  1. Contact NJ IHCAP at 1-888-393-1062
  2. Submit application directly to Maximus Federal Services (contracted review organization)
  3. Include all Humana denial letters, medical records, and physician support

Key Advantage: Independent physician reviewers with HAE expertise evaluate medical necessity, not just insurance company criteria.

Important: IHCAP decisions are binding on Humana if they overturn the denial.

Common Denial Reasons & Solutions

Denial Reason How to Overturn Required Documentation
"No confirmed HAE diagnosis" Submit complete lab panel C4, C1-INH level/function, C1q with reference ranges
"Insufficient attack frequency" Provide detailed attack logs ED visits, missed work, quality of life impact
"Step therapy not completed" Document contraindications/failures Specific reasons other HAE drugs unsuitable
"Not medically necessary" Comprehensive specialist letter Guidelines citations, clinical rationale, monitoring plan
"Experimental/investigational" Cite FDA approval and guidelines FDA labeling, HAE society recommendations

Cost Savings & Support Programs

Manufacturer Support: Takeda offers patient assistance programs, but these typically exclude Medicare and Medicaid beneficiaries. Check Takhzyro patient support for eligibility.

Foundation Assistance: Organizations like the National Organization for Rare Disorders (NORD) and HealthWell Foundation may provide grants for specialty drug copays.

State Programs: New Jersey has various prescription assistance programs for qualifying residents. Contact the NJ Department of Health for current options.

Medicare Extra Help: Low-income Medicare beneficiaries may qualify for Part D premium and cost-sharing assistance.

When to Escalate

Contact NJ Department of Banking and Insurance at 1-800-446-7467 if:

  • Humana violates appeal timelines
  • You experience billing issues after approval
  • You need help navigating the IHCAP process

For Medicare Advantage issues, also contact 1-800-MEDICARE for federal oversight.

Clinician Corner: Medical Necessity Letter Checklist

Essential Elements for Strong PA Requests:

✓ Problem Statement: "Patient has confirmed HAE Type I with recurrent, severe angioedema attacks affecting [specific sites] occurring [frequency]"

✓ Diagnostic Evidence: Include specific lab values with dates and reference ranges

✓ Prior Treatments: Document specific agents tried, duration, outcomes, and reasons for discontinuation

✓ Clinical Rationale: Explain why Takhzyro is medically necessary vs. other options

✓ Guidelines Support: Reference FDA labeling and HAE management guidelines

✓ Monitoring Plan: Describe how you'll track efficacy and safety

✓ Urgency: For expedited requests, clearly state health risks of delay

FAQ

How long does Humana PA take in New Jersey?
Standard decisions within 72 hours; expedited within 24 hours if health could be jeopardized by delay.

What if Takhzyro isn't on my Humana formulary?
Request a formulary exception with clinical documentation showing preferred alternatives are ineffective or contraindicated.

Can I request an expedited appeal?
Yes, if delay could seriously harm your health. Your prescriber must support the urgency in writing.

Does step therapy apply if I failed other HAE drugs outside New Jersey?
Yes, document prior failures regardless of where treatment occurred. Include medical records and specific reasons for discontinuation.

What's the difference between Humana's appeal and IHCAP?
Humana's internal appeal follows Medicare rules; IHCAP is New Jersey's independent external review with physician panels.

How much will Takhzyro cost with Humana coverage?
Varies by plan type and tier. Expect Tier 4 specialty coinsurance (25-33%) until out-of-pocket maximums are reached.

About Counterforce Health

Counterforce Health helps patients, clinicians, and specialty pharmacies turn insurance denials into successful appeals. The platform analyzes denial letters and plan policies to create targeted, evidence-backed appeals that address specific payer criteria. For complex cases like HAE treatments, Counterforce Health's system pulls the right clinical evidence—FDA labeling, peer-reviewed studies, and specialty guidelines—and weaves them into appeals that meet procedural requirements while tracking deadlines and required documentation.

Sources & Further Reading

Disclaimer: This information is for educational purposes only and does not constitute medical or legal advice. Coverage decisions depend on individual plan terms and medical circumstances. Always consult your healthcare provider and insurance plan for personalized guidance. For questions about New Jersey insurance regulations, contact the NJ Department of Banking and Insurance at 1-800-446-7467.

Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.